Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Goodwill (2022 - 2025)

Historic Goodwill for Collegium Pharmaceutical (COLL) over the last 4 years, with Q3 2025 value amounting to $145.9 million.

  • Collegium Pharmaceutical's Goodwill fell 2.33% to $145.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $145.9 million, marking a year-over-year decrease of 2.33%. This contributed to the annual value of $162.3 million for FY2024, which is 2127.34% up from last year.
  • As of Q3 2025, Collegium Pharmaceutical's Goodwill stood at $145.9 million, which was down 2.33% from $147.9 million recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Goodwill ranged from a high of $162.3 million in Q4 2024 and a low of $130.1 million during Q2 2022
  • For the 4-year period, Collegium Pharmaceutical's Goodwill averaged around $138.8 million, with its median value being $133.9 million (2023).
  • As far as peak fluctuations go, Collegium Pharmaceutical's Goodwill skyrocketed by 2127.34% in 2024, and later decreased by 2.33% in 2025.
  • Collegium Pharmaceutical's Goodwill (Quarter) stood at $133.7 million in 2022, then rose by 0.12% to $133.9 million in 2023, then grew by 21.27% to $162.3 million in 2024, then dropped by 10.11% to $145.9 million in 2025.
  • Its Goodwill was $145.9 million in Q3 2025, compared to $147.9 million in Q2 2025 and $150.8 million in Q1 2025.